No Detail Found!

Liver gene therapy: prospects in the snew century

Author(s)
Javed Iqbal Farooqi Department of Gastroenterology, Postgraduate Medical Institute, Hayatabad Medical Complex, Peshawar, Pakistan
Rukhsana Javed Farooqi Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Abstract
Novel and exciting techniques have been developed for the genetic modification of hepatocytes. There are five broadly defined indications for direct gene transfer in liver therapy: 1) Gene replacement therapy, 2) Gene expression therapy, 3) Viral enzyme prodrug therapy, 4) Inhibition of gene expression, and 5) Repair of abnormal genes. The two main methods of gene delivery to the liver are: 1) viral vectors including Retroviruses, Adenoviruses, Adeno-associated, Simian virus 40, hybrid virus vectors, and 2) non-viral methods involving attachment of a therapeutic gene to a carrier. These may be either polymer based cationic carriers (conjugates) or lipid based vectors (liposomes). The last decade of the second millennium has seen a lot of research work done in the field of genetics. Based on the many advances in the field, we hope that there is bright future for clinical applications of gene therapy for hepatic diseases.
Publication Details
Page(s) 343-346
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 5, Year: 2001

Request the full text from PASTIC

Keywords
Liver diseases. Genetic engineering. Gene transfer. Genetic vectors. Transfection Gene therapy
References
Smith RM,Wu GY .1999 .M mbaemdyialatseedidnevfiicvoiegnecnye.JtInhheerritaMpetyfaobrDoisr1n9i9t8h;in21et(sruapnpsc1)a­. r, 37 : 83-92.
.1998 .Hepatocytegrowth correctioonf hemophilia A afterin vivoretrovirgaelne factorinduceshepatocyteproliferatio nin vivo and^ ■ transfeirn factor-VIIdIeficientmice. ProdNatlAcadSciUSA allows forefficientretroviral-mediatgeednetransfeirn ■. Hepatology, 28 : 707-16.
Huber BE .1994 .Genetherapy-promisepsr,oblems| enzyme/prodrugtherapy(VDEPT): selectivelyengineeringdrug sensitivityinto tumors. Ann NY Acad Sc/ and prospectsN.ature, 716 : 104-14.
.1993 .Adenovirus-mediatetdransfeorf low-densitylipoproteinreceptogreneacutelyaccele­r atescholesterocllearancein normalmice. ProcNatlAcad SciUSA, 90 : 2812-6.
Kaneko S,Jaffe HA,HurfordRK JR,Yang Y,Li Q .1992 .Genetherapyof mediatedin vivo genetransfearnd expressio nin normetastaticancerby in vivo retrovirgael netargeting. mal ratliver. Cellularand humoral immune I NatGenets, 995 : 430-5.
Joyce GF .1995 .A generalpurposeRNA-cleav- directegdene therapywith recombinantAdenovirus. I ing DNA enzyme. JViroi, 67 : 2004-15.
Wu CH,Seek J,lian Y,Jona VK,Sengupta K .1998 .. areactiveagainstIntracellulahrepatitisB viralRNA targetsH.epatology, 28 : 547-54.
Wu GY,Wu CH .1992 .Specificinhibitionof hepatitisB viral gene expressionin vitroby targetedantisense oligonucleotidesJ. BiolChem, 267 : 12496-9.
.1993 .In vivo inhibitionof duckhepatitisB virusreplicationand gene expressionby phosphorothioatmeodified antisense oligodeoxynucleotidesE. MBOJ, 12 : 1257-62.
Zhang H,Hanecak R .1999 .Antisense oligonucleotideinhibition of hepatitisC virusgene expressionin liversof mice infectedwithan HCV-vaccinia virusrecombinantA. ntimicrob Agents Chemother, 43 : 347-53.
Wu CH,Wu GY .1998 .Targete dinhibitionof hepatitisC virusdirectedgene expressionin human hepatoma cell lines. Gastroenterology, 114 : 1304-12.
Yoon K,Cole-StrausAs K .1996 .Targetedgene correctioonf episomal DNA in mammalian cellsmediatedby a chimericRNA/DNA oligonucletide. Proc Natl AcadSc/USA, 93 : 2071-6.
Kren BT,Cole-StraussA BT .1997 .Targeted nucleotideexchangein thealkalinephosphatasegene of HuH-7 cells mediatedby a chimericRNA/DNA oligonucleotideH. epatology, 25 : 1462-8.
.1997 .pressionwith FK506 permitslong-termexpressionof therapeuticgenes introducedinto the liver using recombinanatdenovirusesH. epatology, 26 : 949-56.
Yang Y,Nunes FA .1994 .recombinantadenoviruseslimits cellularimmun! and improvestheprospecotf gene therapyof cystic fibrosisN. atGenet, 7 : 1i5-9.
Lee MG .1995 .Theconstitutiveexpre­s sion of the immunomodulatorygp 19K proteinin E1-, E3-adenoviralvectorstronglyreducethe host cytotoxicT cell responseagainstthevectorG. ene Ther, 2 : 256-62.
Amalfitanao ,McVie-WylieAJ .1999 .Systemiccorrection of themuscledisordegrlycogenstoragediseasetype II afterhepatictargetinogf a modifiedAdenovirusvectorencoding human acid-alpha-glucosidaseP. roc Natl AcadSciUSA, 96 : 8861-6.
Wang L .1999 .Sustained correctioonf bleedingdisordeirn hemophilia B mice by genetherapyP. rocNatlAcadSciUSA, 96 : 3906-10.
.1999 .Gene therapyTo the liverusier. simian-virus40-derivedvectorsS.emin LiverDis, 1 : 71-81.
Feng M .1997 .a novel strategtyoachievehigh-efficit cystabletransductioinn vivo. FASEBJ, 11 : 624.
Gao X .1997 .Biochem tocytesmediatedby helpervirus-freHeSV/AAV hybrid. MoiMed, 3 : 813-25.
0

Citations

0

Downloads

88

Views